Cellnovo :'s Diabetes Management System Selected for Inclusion in EUR 4 Million Diabetes Self-Management Project


Cellnovo Group (Paris:CLNV), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, announces that it has been selected to participate in a project, funded by the European Commission's Horizon 2020 programme, aimed at investigating new technologies to help improve the lives of people with Type 1 diabetes. The project, named PEPPER (Patient Empowerment through Predictive Personalised decision support), has a budget of nearly EUR 4 million and brings together leading UK and European universities and companies to research and develop technology that will help to improve the self-management of people with Type 1 diabetes. Researchers working on the project will use Cellnovo's diabetes management system to create a personalised decision support system that will make predictions based on real-time data in order to empower individuals to self-manage their condition. The design of the system will involve patients, clinicians and carers at every stage to ensure that it meets user needs. Sophie Baratte, Chief Executive Officer of Cellnovo, commented: "We are delighted to be participating in PEPPER, which we believe is a strong endorsement of our proprietary technology.